L. Becker Hewes - 02 Jun 2021 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
Chief Medical Officer
Signature
/s/ Ariel Hurley, Attorney-in-Fact
Issuer symbol
BPMC
Transactions as of
02 Jun 2021
Net transactions value
-$115,027
Form type
4
Filing time
17 Sep 2021, 16:14:52 UTC
Next filing
17 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Sale $115,027 -1,292 -4.2% $89.03 29,270 02 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Remarks:

This Form 4 is being filed late due to inadvertent administrative error.